MethodSense, Inc.

MethodSense brings more than 25 years of regulatory and quality expertise to MedTech companies navigating the complex world of medical technology commercialization. With experience spanning 38 countries and more than 1,000 regulatory and quality successes, the firm combines deep regulatory intelligence with hands-on execution to accelerate global market access and reduce costly regulatory setbacks.

MethodSense works alongside medical technology innovators to anticipate regulatory obstacles and develop effective FDA and EU strategies that keep commercialization moving forward. From early regulatory planning through submission execution and ongoing quality management, the firm brings clarity and confidence to complex regulatory decisions while reducing the time and expense of achieving compliance.

LuminLogic®, its AI-enabled compliance platform, makes MethodSense's regulatory and quality expertise accessible through software designed for everyday use. Purpose-built for MedTech, LuminLogic connects regulatory, quality, engineering, and leadership teams through AI-powered regulatory intelligence, configurable workflows, and real-time traceability. The platform simplifies compliance management across the organization, keeping teams informed, aligned, and ready for their next regulatory milestone.

Together, MethodSense and LuminLogic combine hands-on consulting with accessible compliance technology to reduce costs, maintain continuous regulatory readiness, and accelerate time to revenue. This integrated approach enables MedTech companies to focus more resources on innovation and bring life-changing medical technologies to patients sooner.